Artificial superintelligence tops GlobalData’s list of 15 breakthrough technologies redefining life by 2035
The global economy is undergoing seismic shifts, shaped by changing demographics, climate pressures, supply chain upheavals, and mounting geopolitical tensions. Over the next decade, technology adoption and innovation will accelerate as societies adapt to these forces.
15 breakthrough technologies, led by artificial superintelligence, are set to redefine industries and everyday life by 2035, reveals pharma analytics company GlobalData.
GlobalData’s Strategic Intelligence report, “Tech in 2035,” reveals that artificial superintelligence will be the most significant technological breakthrough of the century. Other technologies that are set to reshape our lives include quantum computing, polyfunctional robots, brain-computer interfaces, and small modular reactors. The report examines industry applications and use cases for each technology, offering projections outlining their development trajectories leading up to 2035.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze